Endometrioid carcinoma of the ovary

Changed by Bruno Di Muzio, 26 Sep 2017

Updates to Article Attributes

Body was changed:

Endometrioid carcinomas of the ovary are a a sub-type of an epithelial ovarian tumour tumoursof epithelial origin. The vast majority are malignant and invasive. On imaging, they are usually characterised as complex nonspecific solid-cystic masses and found associated with endometriosis

Epidemiology

Endometrioid carcinomas account for 8-15% of all ovarian carcinomas. It is considered the second commonest malignant ovarian neoplasm 8.

Both endometrioid and clear cell tumours are frequently associated with endometriosis 9

Pathology

The typical gross appearance of these tumours is similar to that of other epithelial lesions, with variable cystic and solid components. Occasionally, it may be completely solid.

Histologically, an endometrioid carcinoma is characterised by the appearance of tubular glands, and bears a strong resemblance to the endometrium. Gross morphological appearance is that of a mass with both solid and cystic areas 2.  Squamous differentiation can be present in more than a third of patients 8.

A benign endometrioid carcinoma is relatively uncommon and when it is benign it tends to be an ovarian cystadenofibroma 3.

Associations
  • synchronous endometrial carcinomaor or endometrial hyperplasia may be present in up to a third of cases
    • the endometrial abnormality is thought to represent an independent, primary lesion rather than metastatic disease
  • endometrioid carcinoma is the most common malignant neoplasm arising within an endometrioma, although overall this is an uncommon occurrence
Location - laterality

Bilateral involvement can be seen in 25-40% of cases 1-2,8.

Radiographic features

General

Imaging findings are often non-specific and include a large, complex cystic mass with solid components.

There may be associated endometrial thickening, evidence of endometriosis or a contralateral mass.

Pelvic MRI

Reported signal characteristics include:

  • T2:
    • relatively low signal intensity of the tumour wall
    • shading sign may be seen 3
  • T1 C + (Gd): can show mild enhancement 3

Treatment and prognosis

An endometriodendometrioid histology may carry a slightly better prognosis than a serous or mucinous cystadenocarcinoma of the ovary (not a serous tumour in general) independent of stage 5,8. Pure endometrioid tumours carry a far better outcome than a mixed variety.

Differential diagnosis

Metastases to the ovary with colon cancer could be considered especially if the ovarian lesion is bilateral or if there is a known colonic mass, especially due to strong histological similarity. Differentiation from metastatic endometrial cancer can also sometimes can be difficult.

See also

  • -<p><strong>Endometrioid carcinomas of the ovary are</strong> a sub-type of an <a href="/articles/ovarian-tumours">ovarian tumour </a>of epithelial origin. The vast majority are malignant and invasive.</p><h4>Epidemiology</h4><p>Endometrioid carcinomas account for 8-15% of all ovarian carcinomas. It is considered the second commonest malignant ovarian neoplasm <sup>8</sup>.</p><h4>Pathology</h4><p>The typical gross appearance of these tumours is similar to that of other epithelial lesions, with variable cystic and solid components. Occasionally, it may be completely solid.</p><p>Histologically, an endometrioid carcinoma is characterised by the appearance of tubular glands, and bears a strong resemblance to the endometrium. Gross morphological appearance is that of a mass with both solid and cystic areas <sup>2</sup>.  Squamous differentiation can be present in more than a third of patients <sup>8</sup>.</p><p>A benign endometrioid carcinoma is relatively uncommon and when it is benign it tends to be an <a href="/articles/ovarian-cystadenofibroma">ovarian cystadenofibroma</a> <sup>3</sup>.</p><h5>Associations</h5><ul>
  • -<li>synchronous <a href="/articles/endometrial-carcinoma">endometrial carcinoma </a>or <a href="/articles/endometrial-hyperplasia-1">endometrial hyperplasia</a> may be present in up to a third of cases<ul><li>the endometrial abnormality is thought to represent an independent, primary lesion rather than metastatic disease</li></ul>
  • +<p><strong>Endometrioid carcinomas of the ovary </strong>are a sub-type of <a title="Epithelial ovarian tumours" href="/articles/epithelial-ovarian-tumours">epithelial </a><a href="/articles/ovarian-tumours">ovarian tumours</a>. The vast majority are malignant and invasive. On imaging, they are usually characterised as complex nonspecific solid-cystic masses and found associated with <a title="Endometriosis" href="/articles/endometriosis">endometriosis</a>. </p><h4>Epidemiology</h4><p>Endometrioid carcinomas account for 8-15% of all ovarian carcinomas. It is considered the second commonest malignant ovarian neoplasm <sup>8</sup>. </p><p>Both endometrioid and <a title="Clear cell ovarian carcinoma" href="/articles/clear-cell-ovarian-carcinoma">clear cell tumours</a> are frequently associated with endometriosis <sup>9</sup>. </p><h4>Pathology</h4><p>The typical gross appearance of these tumours is similar to that of other epithelial lesions, with variable cystic and solid components. Occasionally, it may be completely solid.</p><p>Histologically, an endometrioid carcinoma is characterised by the appearance of tubular glands and bears a strong resemblance to the endometrium. Gross morphological appearance is that of a mass with both solid and cystic areas <sup>2</sup>.  Squamous differentiation can be present in more than a third of patients <sup>8</sup>.</p><p>A benign endometrioid carcinoma is relatively uncommon and when it is benign it tends to be an <a href="/articles/ovarian-cystadenofibroma">ovarian cystadenofibroma</a> <sup>3</sup>.</p><h5>Associations</h5><ul>
  • +<li>synchronous <a href="/articles/endometrial-carcinoma">endometrial carcinoma</a> or <a href="/articles/endometrial-hyperplasia-1">endometrial hyperplasia</a> may be present in up to a third of cases<ul><li>the endometrial abnormality is thought to represent an independent, primary lesion rather than metastatic disease</li></ul>
  • -</ul><h5>Location - laterality</h5><p>Bilateral involvement can be seen in 25-40% of cases <sup>1-2,8</sup>.</p><h4>Radiographic features</h4><h5>General</h5><p>Imaging findings are often non-specific and include a large, complex cystic mass with solid components.</p><p>There may be associated <a href="/articles/endometrial-thickening">endometrial thickening</a>, evidence of <a href="/articles/endometriosis">endometriosis</a> or a contralateral mass.</p><h5>Pelvic MRI</h5><p>Reported signal characteristics include</p><ul>
  • +</ul><h5>Location - laterality</h5><p>Bilateral involvement can be seen in 25-40% of cases <sup>1-2,8</sup>.</p><h4>Radiographic features</h4><p>Imaging findings are often non-specific and include a large, complex cystic mass with solid components.</p><p>There may be associated <a href="/articles/endometrial-thickening">endometrial thickening</a>, evidence of <a href="/articles/endometriosis">endometriosis</a> or a contralateral mass.</p><h5>MRI</h5><p>Reported signal characteristics include:</p><ul>
  • -<li>a <a href="/articles/shading-sign">shading sign</a> may be seen <sup>3</sup>
  • +<li>
  • +<a href="/articles/shading-sign-endometrioma">shading sign</a> may be seen <sup>3</sup>
  • -</ul><h4>Treatment and prognosis</h4><p>An endometriod histology may carry a slightly better prognosis than a serous or mucinous cystadenocarcinoma of the ovary (not a serous tumour in general) independent of stage <sup>5,8</sup>. Pure endometrioid tumours carry a far better outcome than a mixed variety.</p><h4>Differential diagnosis</h4><p>Metastases to the ovary with <a href="/articles/colorectal-carcinoma">colon cancer</a> could be considered especially if the ovarian lesion is bilateral or if there is a known colonic mass, especially due to strong histological similarity. Differentiation from metastatic <a href="/articles/endometrial-carcinoma">endometrial cancer</a> can also sometimes can be difficult.</p><h4>See also</h4><ul><li><a href="/articles/ovarian-tumours">ovarian tumours</a></li></ul>
  • +</ul><h4>Treatment and prognosis</h4><p>An endometrioid histology may carry a slightly better prognosis than a serous or mucinous cystadenocarcinoma of the ovary (not a serous tumour in general) independent of stage <sup>5,8</sup>. Pure endometrioid tumours carry a far better outcome than a mixed variety.</p><h4>Differential diagnosis</h4><p>Metastases to the ovary with <a href="/articles/colorectal-carcinoma">colon cancer</a> could be considered especially if the ovarian lesion is bilateral or if there is a known colonic mass, especially due to strong histological similarity. Differentiation from metastatic <a href="/articles/endometrial-carcinoma">endometrial cancer</a> can also sometimes be difficult.</p><h4>See also</h4><ul><li><a href="/articles/ovarian-tumours">ovarian tumours</a></li></ul>

References changed:

  • 9. Foti PV, Attinà G, Spadola S, Caltabiano R, Farina R, Palmucci S, Zarbo G, Zarbo R, D'Arrigo M, Milone P, Ettorre GC. MR imaging of ovarian masses: classification and differential diagnosis. Insights into imaging. 7 (1): 21-41. <a href="https://doi.org/10.1007/s13244-015-0455-4">doi:10.1007/s13244-015-0455-4</a> - <a href="https://www.ncbi.nlm.nih.gov/pubmed/26671276">Pubmed</a> <span class="ref_v4"></span>

ADVERTISEMENT: Supporters see fewer/no ads

Updating… Please wait.

 Unable to process the form. Check for errors and try again.

 Thank you for updating your details.